FGFR2 and gastrointestinal stromal tumor: Based on our data, which illustrate a tight cross-talk between FGFR2 and CLDN1 (Figure 5, Figure 6 and Figure 8), CLDN1 may serve as a potent regulator of FGFR signaling in GIST, thereby maintaining resistance to IM and promoting disease progression.